Open access · OA
via Europe PMC
Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention
Authors not listed
Innovation in aging · 2025
Abstract
This article reviews clinical trials involving senolytics(definition) for the treatment and prevention of Alzheimer’s disease. Published in Innovation in Aging, 2025.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
Anonymous. (2025). Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12761975
Vancouver
Anonymous. Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention. Innovation in aging. 2025.
BibTeX
@article{anon2025Clinic,
title = {Clinical Trials of Senolytics in Alzheimer’s Disease Treatment and Prevention},
author = {Anonymous},
journal = {Innovation in aging},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014
Open access · OA
Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment
Springer eBooks 2015
Citation only
Prevention of Neurodegeneration for Alzheimer’s Disease by Lycium barbarum
European Journal of Medicinal Chemistry 2021
Citation only